SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-12G/A - Registration of securities [Section 12(g)]: [Amend]
SEC Accession No. 0001104659-13-092092
Filing Date
2013-12-24
Accepted
2013-12-23 19:48:07
Documents
4

Document Format Files

Seq Description Document Type Size
1 10-12G/A a13-27065_11012ga.htm 10-12G/A 50221
2 EX-10.7 a13-27065_1ex10d7.htm EX-10.7 64029
3 EX-99.1 a13-27065_1ex99d1.htm EX-99.1 1302125
4 filename4.htm CORRESP 22458
  Complete submission text file 0001104659-13-092092.txt   1439895
Mailing Address 420 LEXINGTON AVENUE SUITE 2012 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 2012 NEW YORK NY 10170 212-297-0020
ContraVir Pharmaceuticals, Inc. (Filer) CIK: 0001583771 (see all company filings)

IRS No.: 462783806 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-12G/A | Act: 34 | File No.: 000-55020 | Film No.: 131296162
SIC: 2834 Pharmaceutical Preparations